Skip to main content
Coeptis Therapeutics Holdings, Inc. (COEP)
Apr 24, 2026 - COEP merged into ZSQR
16.40
+0.19 (1.17%)
Inactive · Last trade price on Apr 24, 2026

COEP Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Net Income
-11.92-10.68-21.27-37.57-13.45
Upgrade
Depreciation & Amortization
1.221.041.0410.45
Upgrade
Other Amortization
0.550.22---
Upgrade
Loss (Gain) From Sale of Investments
0.09----
Upgrade
Stock-Based Compensation
5.872.447.5128.7110.15
Upgrade
Other Operating Activities
-2.950.463.754.531.34
Upgrade
Change in Accounts Receivable
--0.01-0.010.02
Upgrade
Change in Accounts Payable
-0.38-0.151.32-0.04-1.58
Upgrade
Change in Unearned Revenue
-----1
Upgrade
Change in Other Net Operating Assets
-1.080.020.4-0.51-0.42
Upgrade
Operating Cash Flow
-8.6-6.65-7.24-3.88-4.49
Upgrade
Sale (Purchase) of Intangibles
-----1.75
Upgrade
Investing Cash Flow
-----1.75
Upgrade
Long-Term Debt Issued
0.991.850.65-0.08
Upgrade
Total Debt Issued
0.991.850.65-0.08
Upgrade
Long-Term Debt Repaid
-0.22-0.65-1.23-2.42-1.7
Upgrade
Total Debt Repaid
-0.22-0.65-1.23-2.42-1.7
Upgrade
Net Debt Issued (Repaid)
0.771.2-0.58-2.42-1.62
Upgrade
Issuance of Common Stock
7.520.15.298.5210.14
Upgrade
Repurchase of Common Stock
-----0.25
Upgrade
Other Financing Activities
-0.50.2-0.61-0.05
Upgrade
Financing Cash Flow
13.745.714.925.498.22
Upgrade
Net Cash Flow
5.14-0.94-2.321.611.98
Upgrade
Free Cash Flow
-8.6-6.65-7.24-3.88-4.49
Upgrade
Free Cash Flow Margin
-631.16%----5985.92%
Upgrade
Free Cash Flow Per Share
-2.03-3.46-5.64-5.42-8.23
Upgrade
Cash Interest Paid
0.010.01---
Upgrade
Levered Free Cash Flow
-3.03-1.81-3.398-3.05
Upgrade
Unlevered Free Cash Flow
-3.18-1.73-3.328.14-2.93
Upgrade
Change in Working Capital
-1.46-0.131.73-0.55-2.98
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.